SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-253092
Filing Date
2023-10-10
Accepted
2023-10-10 07:35:58
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d558787ddefa14a.htm DEFA14A 51072
2 EX-2.1 d558787dex21.htm EX-2.1 565248
3 EX-3.1 d558787dex31.htm EX-3.1 4869
4 EX-3.2 d558787dex32.htm EX-3.2 6232
5 EX-99.1 d558787dex991.htm EX-99.1 49531
6 EX-99.2 d558787dex992.htm EX-99.2 67898
  Complete submission text file 0001193125-23-253092.txt   745789
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35921 | Film No.: 231315662
SIC: 2834 Pharmaceutical Preparations